Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yapeng Su

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Cancer Research|October 15, 2025
A Roadmap for the Future of Systems Biology in Cancer ResearchH Steven Wiley, Carlos F Lopez, Andrei S Rodin, et al.
Nature Communications|April 15, 2026
Sequential transcriptional waves and NF-κB-driven chromatin remodeling direct drug-induced dedifferentiation in cancerYapeng Su, Chunmei Liu, Xiang Lu, et al.
Medrxiv : the Preprint Server for Health Sciences|September 30, 2020
Reinfection with SARS-CoV-2 and Failure of Humoral Immunity: a case reportJason D Goldman, Kai Wang, Katharina Röltgen, et al.
Biorxiv : the Preprint Server for Biology|January 4, 2022
Human KIR <sup>+</sup> CD8 <sup>+</sup> T cells target pathogenic T cells in Celiac disease and are active in autoimmune diseases and COVID-19Jing Li, Maxim Zaslavsky, Yapeng Su, et al.
Vaccines|January 21, 2023
Reinfection with SARS-CoV-2 and Waning Humoral Immunity: A Case ReportJason D Goldman, Kai Wang, Katharina Röltgen, et al.
Nature Communications|May 12, 2026
Whole-protein screening and multi-modal profiling of antigen-specific CD4<sup>+</sup> T cells at single-cell resolutionRongyu Zhang, Jingqi Qi, Michaela McKasson, et al.
Science (New York, N.Y.)|March 8, 2022
KIR<sup>+</sup>CD8<sup>+</sup> T cells suppress pathogenic T cells and are active in autoimmune diseases and COVID-19Jing Li, Maxim Zaslavsky, Yapeng Su, et al.
Biorxiv : the Preprint Server for Biology|August 9, 2020
Multiomic Immunophenotyping of COVID-19 Patients Reveals Early Infection TrajectoriesYapeng Su, Daniel Chen, Christopher Lausted, et al.
Immunity|September 30, 2021
Early IFN-α signatures and persistent dysfunction are distinguishing features of NK cells in severe COVID-19Benjamin Krämer, Rainer Knoll, Lorenzo Bonaguro, et al.
Cell|November 10, 2020
Multi-Omics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19Yapeng Su, Daniel Chen, Dan Yuan, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Cancer Research|October 15, 2025
A Roadmap for the Future of Systems Biology in Cancer ResearchH Steven Wiley, Carlos F Lopez, Andrei S Rodin, et al.
Nature Communications|April 15, 2026
Sequential transcriptional waves and NF-κB-driven chromatin remodeling direct drug-induced dedifferentiation in cancerYapeng Su, Chunmei Liu, Xiang Lu, et al.
Medrxiv : the Preprint Server for Health Sciences|September 30, 2020
Reinfection with SARS-CoV-2 and Failure of Humoral Immunity: a case reportJason D Goldman, Kai Wang, Katharina Röltgen, et al.
Biorxiv : the Preprint Server for Biology|January 4, 2022
Human KIR <sup>+</sup> CD8 <sup>+</sup> T cells target pathogenic T cells in Celiac disease and are active in autoimmune diseases and COVID-19Jing Li, Maxim Zaslavsky, Yapeng Su, et al.
Vaccines|January 21, 2023
Reinfection with SARS-CoV-2 and Waning Humoral Immunity: A Case ReportJason D Goldman, Kai Wang, Katharina Röltgen, et al.
Nature Communications|May 12, 2026
Whole-protein screening and multi-modal profiling of antigen-specific CD4<sup>+</sup> T cells at single-cell resolutionRongyu Zhang, Jingqi Qi, Michaela McKasson, et al.
Science (New York, N.Y.)|March 8, 2022
KIR<sup>+</sup>CD8<sup>+</sup> T cells suppress pathogenic T cells and are active in autoimmune diseases and COVID-19Jing Li, Maxim Zaslavsky, Yapeng Su, et al.
Biorxiv : the Preprint Server for Biology|August 9, 2020
Multiomic Immunophenotyping of COVID-19 Patients Reveals Early Infection TrajectoriesYapeng Su, Daniel Chen, Christopher Lausted, et al.
Immunity|September 30, 2021
Early IFN-α signatures and persistent dysfunction are distinguishing features of NK cells in severe COVID-19Benjamin Krämer, Rainer Knoll, Lorenzo Bonaguro, et al.
Cell|November 10, 2020
Multi-Omics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19Yapeng Su, Daniel Chen, Dan Yuan, et al.
Pageof 6